| Patent | Date |
|---|
Methods of treatment using allosteric processing inhibitors for matrix metalloproteinases
Grant 8,883,473 - Leonard , et al. November 11, 2 | 2014-11-11 |
Methods for designing, selecting and/or optimizing allosteric processing inhibitors for matrix metalloproteinases
Grant 8,798,939 - Leonard , et al. August 5, 2 | 2014-08-05 |
Crystal structure of the pro form of a matrix metalloproteinase and an allosteric processing inhibitor
Grant 8,753,857 - Leonard , et al. June 17, 2 | 2014-06-17 |
Crystal Structure of the Pro Form of a Matrix Metalloproteinase and an Allosteric Processing Inhibitor
App 20130166268 - Leonard; Kristi A. ; et al. | 2013-06-27 |
Crystal Structure of the Pro Form of a Matrix Metalloproteinase and an Allosteric Processing Inhibitor
App 20130040360 - Leonard; Kristi A. ; et al. | 2013-02-14 |
Methods of Treatment Using Allosteric Processing Inhibitors for Matrix Metalloproteinases
App 20130040994 - Leonard; Kristi A. ; et al. | 2013-02-14 |
Arylindenopyrimidines compound and use as an adenosine A2a receptor antagonists
Grant 8,017,614 - Shook , et al. September 13, 2 | 2011-09-13 |
ARYL SUBSTITUTED ARYLINDENOPYRIMIDINES AND THEIR USE AS HIGHLY SELECTIVE ADENOSINE A2a RECEPTOR ANTAGONISTS
App 20110105492 - Jackson; Paul F. ; et al. | 2011-05-05 |
Heteroaryl Substituted Arylindenopyrimidines And Their Use As Highly Selective Adenosine A2a Receptor Antagonists
App 20110105494 - JACKSON; Paul F. ; et al. | 2011-05-05 |
HETEROCYCLYL SUBSTITUTED ARYLINDENOPYRIMIDINES AND THEIR USE AS HIGHLY SELECTIVE ADENOSINE A2a RECEPTOR ANTAGONISTS
App 20110105493 - JACKSON; Paul F. ; et al. | 2011-05-05 |
2-AMINO-9-[4-(4-METHOXY-PHENOXY)-PIPERIDIN-1-YL]-4-PHENYL-INDENO[1,2-D]PYR- IMIDIN-5-ONE AND ITS USE AS A HIGHLY SELECTIVE ADENOSINE A2a RECEPTOR ANTAGONIST
App 20110105540 - JACKSON; Paul F. ; et al. | 2011-05-05 |
ALKYL SUBSTITUTED ARYLINDENOPYRIMIDINES AND THEIR USE AS HIGHLY SELECTIVE ADENOSINE A2a RECEPTOR ANTAGONISTS
App 20110105541 - Jackson; Paul F. ; et al. | 2011-05-05 |
ARYLINDENOPYRIMIDINES AND THEIR USE AS ADENOSINE A2a
App 20090111804 - SHOOK; Brian C. ; et al. | 2009-04-30 |
ARYLINDENOPYRIMIDINES COMPOUND AND USE AS AN ADENOSINE A2a RECEPTOR ANTAGONISTS
App 20090111827 - SHOOK; Brian C. ; et al. | 2009-04-30 |
Arylindenopyridines and related therapeutic and prophylactic methods
App 20060154949 - Heintzelman; Geoffrey R. ; et al. | 2006-07-13 |
Arylindenopyridines and related therapeutic and prophylactic methods
App 20050239782 - Heintzelman, Geoffrey R. ; et al. | 2005-10-27 |
Benzenedicarboxylic acid derivatives
App 20050171065 - Jackson, Paul F. ; et al. | 2005-08-04 |
Arylindenopyridines and related therapeutic and prophylactic methods
Grant 6,903,109 - Heintzelman , et al. June 7, 2 | 2005-06-07 |
Substituted 3-(2,5-disubstituted)pyridyl-4-aryl pyrroles for treating inflammatory diseases
App 20050043331 - Bullington, James L. ; et al. | 2005-02-24 |
Benzenedicarboxylic acid derivatives
Grant 6,852,750 - Jackson , et al. February 8, 2 | 2005-02-08 |
Arylindenopyridines and related therapeutic and prophylactic methods
App 20040082578 - Heintzelman, Geoffrey R. ; et al. | 2004-04-29 |
PARP inhibitors, pharmaceutical compositions comprising same, and methods of using same
Grant 6,635,642 - Jackson , et al. October 21, 2 | 2003-10-21 |
Benzenedicarboxylic acid derivatives
App 20030083505 - Jackson, Paul F. ; et al. | 2003-05-01 |
NAALADase inhibitors useful as pharmaceutical compounds and compositions
App 20030083374 - Jackson, Paul F. ; et al. | 2003-05-01 |
Compounds, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage
Grant 6,514,983 - Li , et al. February 4, 2 | 2003-02-04 |
NAALADase inhibitors
Grant 6,479,471 - Jackson , et al. November 12, 2 | 2002-11-12 |
Methods of cancer treatment using naaladase inhibitors
App 20020151503 - Slusher, Barbara S. ; et al. | 2002-10-17 |
NAALADase inhibitors useful as pharmaceutical compounds and compositions
Grant 6,458,775 - Jackson , et al. October 1, 2 | 2002-10-01 |
Benzenedicarboxylic acid derivatives
Grant 6,452,044 - Jackson , et al. September 17, 2 | 2002-09-17 |
Alkoxy-substituted compounds, methods and compositions for inhibiting parp activity
Grant 6,426,415 - Jackson , et al. July 30, 2 | 2002-07-30 |
Pharmaceutical compositions and methods of effecting a neuronal activity in an animal using naaladase inhibitors
Grant 6,413,948 - Slusher , et al. July 2, 2 | 2002-07-02 |
Methods of cancer treatment using NAALADase inhibitors
Grant 6,372,726 - Slusher , et al. April 16, 2 | 2002-04-16 |
Thioalkyl Compounds, Methods, And Compositions For Inhibiting Parp Activity
App 20020028813 - JACKSON, PAUL F. ; et al. | 2002-03-07 |
Benzenedicarboxylic acid derivatives
App 20020019430 - Jackson, Paul F. ; et al. | 2002-02-14 |
Poly(ADP-ribose) polymerase inhibitors and method for treating neural or cardiovascular tissue damage using the same
Grant 6,346,536 - Li , et al. February 12, 2 | 2002-02-12 |
Hydroxamic acid derivatives
App 20010044459 - Jackson, Paul F. ; et al. | 2001-11-22 |
Phosphonic acid derivatives
Grant 6,288,046 - Jackson , et al. September 11, 2 | 2001-09-11 |
Hydroxamic acid derivatives
Grant 6,271,245 - Jackson , et al. August 7, 2 | 2001-08-07 |
Thio-substituted pentanedioic acid derivatives
Grant 6,265,609 - Jackson , et al. July 24, 2 | 2001-07-24 |
Alkoxy-substituted compounds, methods, and compositions for inhibiting PARP activity
Grant 6,197,785 - Jackson , et al. March 6, 2 | 2001-03-06 |
Di-n-heterocyclic compounds, methods, and compositions for inhibiting parp activity
Grant 6,121,278 - Jackson , et al. September 19, 2 | 2000-09-19 |
Phosphinic acid derivatives
Grant 6,121,252 - Jackson , et al. September 19, 2 | 2000-09-19 |
Phosphinic alkanoic acid derivatives
Grant 6,071,965 - Jackson , et al. June 6, 2 | 2000-06-06 |
Phosphonic acid derivatives
Grant 6,054,444 - Jackson , et al. April 25, 2 | 2000-04-25 |
NAALADase inhibitors
Grant 6,046,180 - Jackson , et al. April 4, 2 | 2000-04-04 |
Certain dioic acid derivatives useful as NAALADase inhibitors
Grant 6,025,344 - Jackson , et al. February 15, 2 | 2000-02-15 |
Inhibitors of NAALADase enzyme activity
Grant 6,025,345 - Jackson , et al. February 15, 2 | 2000-02-15 |
Pharmaceutical compositions and methods of treating a glutamate abnormality and effecting a neuronal activity in an animal using NAALADase inhibitors
Grant 6,017,903 - Slusher , et al. January 25, 2 | 2000-01-25 |
Methods of cancer treatment using naaladase inhibitors
Grant 6,011,021 - Slusher , et al. January 4, 2 | 2000-01-04 |
Treatment of global and focal ischemia using naaladase inhibitors
Grant 6,004,946 - Slusher , et al. December 21, 1 | 1999-12-21 |
Naaladase inhibitors
Grant 5,968,915 - Jackson , et al. October 19, 1 | 1999-10-19 |
Hydroxamic acid derivatives
Grant 5,962,521 - Jackson , et al. October 5, 1 | 1999-10-05 |
Certain sulfoxide and sulfone derivatives
Grant 5,902,817 - Jackson , et al. May 11, 1 | 1999-05-11 |
Naaladase inhibitors
Grant 5,880,112 - Jackson , et al. March 9, 1 | 1999-03-09 |
Phosphoramidate derivatives
Grant 5,863,536 - Jackson , et al. January 26, 1 | 1999-01-26 |
Treatment of global and focal ischemia using naaladase inhibitors
Grant 5,824,662 - Slusher , et al. October 20, 1 | 1998-10-20 |
Methods of cancer treatment using naaladase inhibitors
Grant 5,804,602 - Slusher , et al. September 8, 1 | 1998-09-08 |
Inhibitors of NAALADase enzyme activity
Grant 5,795,877 - Jackson , et al. August 18, 1 | 1998-08-18 |
Certain phosphonomethyl-pentanedioic acid derivatives thereof
Grant 5,672,592 - Jackson , et al. September 30, 1 | 1997-09-30 |
Substituted nitrogen heterocycles
Grant 5,502,048 - Chapdelaine , et al. March 26, 1 | 1996-03-26 |
| 